CTI BIOPHARMA CORP Annual Interest Expense in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cti Biopharma Corp quarterly/annual Interest Expense history and growth rate from 2010 to 2022.
  • Cti Biopharma Corp Interest Expense for the quarter ending March 31, 2023 was $4.18M, a 103% increase year-over-year.
  • Cti Biopharma Corp Interest Expense for the twelve months ending March 31, 2023 was $15.3M, a 256% increase year-over-year.
  • Cti Biopharma Corp annual Interest Expense for 2022 was $13.1M, a 444% increase from 2021.
  • Cti Biopharma Corp annual Interest Expense for 2021 was $2.42M, a 192% increase from 2020.
  • Cti Biopharma Corp annual Interest Expense for 2020 was $828K, a 17.4% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $13.1M +$10.7M +444% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-06
2021 $2.42M +$1.59M +192% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $828K -$174K -17.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $1M -$207K -17.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $1.21M -$663K -35.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $1.87M -$742K -28.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $2.61M +$510K +24.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 $2.1M +$157K +8.06% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $1.95M +$921K +89.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 $1.03M +$970K +1732% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-17
2012 $56K -$814K -93.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $870K -$1.34M -60.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 $2.21M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.